PIP and breast carcinoma: Evaluating the immunohistochemical cytokeratin profile of the lesion in terms of CK7 and CK20 was useful when distinguishing between pulmonary adenocarcinoma and metastatic pulmonary tumor was difficult, along with levels of the lung cancer marker TTF-1 and the breast cancer marker GCDFP-15.